Artificial Intelligence has suddenly gone from the fringes of science to being everywhere. So how did we get here? And where's this all heading? In this new series of Science Friction, we're finding out.
…
continue reading
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!
Siirry offline-tilaan Player FM avulla!
Spotlight: The ‘new thalidomide’
MP3•Jakson koti
Manage episode 356179139 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
In the UK, three babies are still being born each month after being exposed to sodium valproate. This is despite the risk of foetal valproate spectrum disorder being known about for many years. In the first of a series of shorter ‘Spotlight’ episodes, executive editor Nigel Praities speaks with senior data journalist, Julia Robinson, about her recent investigation into this issue and whether NHS England is on track to meet its target to reduce the use of the drug in people who can get pregnant by 50% by the end of 2023. Julia also gives an insight into new research that may suggest the risks from sodium valproate and other drugs used for epilepsy may have been underestimated. Click here to read the full investigation: https://pharmaceutical-journal.com/article/feature/why-is-the-uk-struggling-to-contain-its-sodium-valproate-problem This episode was produced by Geoff Marsh.
…
continue reading
48 jaksoa
MP3•Jakson koti
Manage episode 356179139 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
In the UK, three babies are still being born each month after being exposed to sodium valproate. This is despite the risk of foetal valproate spectrum disorder being known about for many years. In the first of a series of shorter ‘Spotlight’ episodes, executive editor Nigel Praities speaks with senior data journalist, Julia Robinson, about her recent investigation into this issue and whether NHS England is on track to meet its target to reduce the use of the drug in people who can get pregnant by 50% by the end of 2023. Julia also gives an insight into new research that may suggest the risks from sodium valproate and other drugs used for epilepsy may have been underestimated. Click here to read the full investigation: https://pharmaceutical-journal.com/article/feature/why-is-the-uk-struggling-to-contain-its-sodium-valproate-problem This episode was produced by Geoff Marsh.
…
continue reading
48 jaksoa
Kaikki jaksot
×Tervetuloa Player FM:n!
Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.